IMARC Group's report titled " PET-CT Scanner Device Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on the global PET-CT scanner device market share. The global market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2028, exhibiting a growth rate (CAGR) of 3.93% during 2023-2028.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample

Factors Affecting the Growth of the PET-CT Scanner Device Industry:

• Increasing Incidence of Cancer:

PET-CT scanners are highly effective in detecting cancer at an early stage, even before symptoms manifest. This early detection enables prompt initiation of treatment, leading to better patient outcomes and survival rates. PET-CT imaging also provides detailed information about the extent and spread of cancer within the body, facilitating accurate staging of the disease. This information is crucial for developing personalized treatment plans tailored as per the specific condition of patients.

• Advancements in Imaging Technology:

Ongoing advancements in PET-CT imaging technology result in improved image quality, resolution, and clarity. This enables healthcare providers to obtain more accurate and detailed images of anatomical structures and metabolic processes, leading to better diagnostic accuracy and confidence in clinical decision-making. Moreover, innovations in PET-CT scanners are leading to faster scan times, allowing healthcare facilities to increase patient throughput and efficiency. Shorter scan times also enhance patient comfort and satisfaction while reducing the overall cost and time burden associated with imaging procedures.

• Rising Demand for Personalized Medicine:

PET-CT scanners play a crucial role in personalized medicine by providing detailed information about the molecular and metabolic characteristics of tumors. This enables healthcare providers to accurately diagnose cancer subtypes and assess the response of patients to specific treatments, facilitating personalized treatment planning tailored as per the unique biological profile of each patient. In addition, PET-CT imaging is used to monitor the response of patients to various cancer therapies, including chemotherapy, radiation therapy, and targeted therapies. By detecting metabolic changes in tumors over time, PET-CT scans help healthcare providers evaluate treatment efficacy, identify early signs of treatment resistance, and make informed decisions regarding treatment adjustments or modifications.

Leading Companies Operating in the Global PET-CT Scanner Device Industry:

• Bruker Corporation
• Canon Medical Systems Usa Inc.
• General Electric Company
• Hitachi Ltd.
• Koninklijke Philips N.V.
• Mediso Ltd.
• Neusoft Corporation
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthcare GmbH (Siemens AG)
• Sofie Biosciences Inc.
• United Imaging Healthcare Co. Ltd.
• Yangzhou Kindsway Biotech Co. Ltd.

PET-CT Scanner Device Market Report Segmentation:

By Type:

• Stationary Scanners
• Portable Scanners/Mobile Scanners

Stationary Scanners represent the largest segment due to their higher image quality, reliability, and suitability for a wide range of clinical applications.

By Slice Count:

• Low Slice Scanner (<64 Slices)
• Medium Slice Scanner (64 Slices)
• High Slice Scanner (>64 Slices)
   

Medium slice scanner (64 Slices) accounts for the majority of the market share as it offers a balance between image resolution and cost-effectiveness, making it a popular choice among healthcare providers.

By Isotope and Detector Type:

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• Gallium
• Thallium
• Others
   

Flurodeoxyglucose (FDG) exhibits clear dominance in the market owing to its widespread availability, established efficacy in cancer imaging, and reimbursement support,

By Service Provider:

• Hospitals
• Diagnostic Centers
• Research Institutes 

Hospitals hold the biggest market share driven by their comprehensive diagnostic and treatment services, including PET-CT imaging, to a wide patient population.

By Application:

• Oncology
• Neurology
• Cardiology
• Others

Oncology dominates the market, which can be attributed to the utilization of PET-CT imaging in cancer diagnosis, staging, treatment planning, and response assessment.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Asia Pacific enjoys the leading position in the PET-CT scanner device market on account of the increasing healthcare infrastructure investment, rising prevalence of cancer, and the growing adoption of advanced medical imaging technologies.

Global PET-CT Scanner Device Market Trends:

Innovations in PET-CT imaging technology, such as improved image resolution, faster scan times, and enhanced software capabilities, are strengthening the growth of the market.

Increasing emphasis on personalized medicine and precision oncology is fueling the adoption of PET-CT scanners for accurate diagnosis, treatment planning, and therapy response assessment.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163